IDV vehicle

75F40123D00003

INDEFINITE DELIVERY, INDEFINITE QUANTITY (IDIQ) CONTRACT TO PROVIDE ANIMAL HUSBANDRY SERVICES AND VIVARIUM MANAGEMENT FOR CBER/CDER AND CDRH WITH A 5 YEAR ORDERING PERIOD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCR416 — Veterinary/Animal Care Services
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeORDER DEPENDENT (IDV ALLOWS PRICING ARRANGEMENT TO BE DETERMINED SEPARATELY FOR EACH ORDER)
Obligations$25.0K
Current contract valueNot reported
Potential contract value / ceiling$25.0M
Start dateMar 2, 2023
Current end dateNot available
Potential end dateNot available
Latest award activityMar 24, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 24, 2026P00004$0INDEFINITE DELIVERY, INDEFINITE QUANTITY (IDIQ) CONTRACT TO PROVIDE ANIMAL HUSBANDRY SERVICES AND VIVARIUM MANAGEMENT FOR CBER/CDER AND CDRH WITH A 5 YEAR ORDERING PERIOD
Nov 18, 2025P00003$0COR CHANGE AND UPDATE FAR/HHSAR CLAUSES INDEFINITE DELIVERY, INDEFINITE QUANTITY (IDIQ) CONTRACT TO PROVIDE ANIMAL HUSBANDRY SERVICES AND VIVARIUM MANAGEMENT FOR CBER/CDER AND CDRH WITH A 5 YEAR ORDERING PERIOD

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Yolanda RankinContactyolanda.rankin@fda.hhs.gov
2142534954
SourceDec 21, 2021

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.